Logo image of LHCG

LHC GROUP INC (LHCG) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:LHCG - US50187A1079 - Common Stock

169.81 USD
+0.8 (+0.47%)
Last: 2/21/2023, 8:24:00 PM
169.81 USD
0 (0%)
After Hours: 2/21/2023, 8:24:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to LHCG. LHCG was compared to 103 industry peers in the Health Care Providers & Services industry. LHCG has an average financial health and profitability rating. LHCG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • LHCG had positive earnings in the past year.
  • In the past year LHCG has reported a negative cash flow from operations.
LHCG Yearly Net Income VS EBIT VS OCF VS FCFLHCG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 200M 400M

1.2 Ratios

  • LHCG's Return On Assets of 2.16% is fine compared to the rest of the industry. LHCG outperforms 66.09% of its industry peers.
  • With a decent Return On Equity value of 3.94%, LHCG is doing good in the industry, outperforming 66.09% of the companies in the same industry.
  • The Return On Invested Capital of LHCG (4.20%) is better than 62.61% of its industry peers.
Industry RankSector Rank
ROA 2.16%
ROE 3.94%
ROIC 4.2%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LHCG Yearly ROA, ROE, ROICLHCG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2 4 6 8 10

1.3 Margins

  • LHCG has a better Profit Margin (2.73%) than 65.22% of its industry peers.
  • In the last couple of years the Profit Margin of LHCG has grown nicely.
  • Looking at the Operating Margin, with a value of 6.15%, LHCG is in the better half of the industry, outperforming 68.70% of the companies in the same industry.
  • In the last couple of years the Operating Margin of LHCG has grown nicely.
  • Looking at the Gross Margin, with a value of 38.62%, LHCG is in the better half of the industry, outperforming 68.70% of the companies in the same industry.
  • LHCG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.15%
PM (TTM) 2.73%
GM 38.62%
OM growth 3Y2.47%
OM growth 5Y2.07%
PM growth 3Y14.06%
PM growth 5Y5.1%
GM growth 3Y3.28%
GM growth 5Y0.9%
LHCG Yearly Profit, Operating, Gross MarginsLHCG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 10 20 30

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LHCG is destroying value.
  • The number of shares outstanding for LHCG has been reduced compared to 1 year ago.
  • Compared to 1 year ago, LHCG has a worse debt to assets ratio.
LHCG Yearly Shares OutstandingLHCG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 10M 20M 30M
LHCG Yearly Total Debt VS Total AssetsLHCG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 3.80 indicates that LHCG is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.80, LHCG belongs to the top of the industry, outperforming 80.87% of the companies in the same industry.
  • LHCG has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
  • LHCG's Debt to Equity ratio of 0.46 is fine compared to the rest of the industry. LHCG outperforms 64.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z 3.8
ROIC/WACC0.5
WACC8.35%
LHCG Yearly LT Debt VS Equity VS FCFLHCG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 500M 1B 1.5B

2.3 Liquidity

  • LHCG has a Current Ratio of 1.45. This is a normal value and indicates that LHCG is financially healthy and should not expect problems in meeting its short term obligations.
  • LHCG has a Current ratio (1.45) which is in line with its industry peers.
  • LHCG has a Quick Ratio of 1.45. This is a normal value and indicates that LHCG is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of LHCG (1.45) is better than 61.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 1.45
LHCG Yearly Current Assets VS Current LiabilitesLHCG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 200M 400M 600M

4

3. Growth

3.1 Past

  • The earnings per share for LHCG have decreased strongly by -25.09% in the last year.
  • The Earnings Per Share has been growing by 22.42% on average over the past years. This is a very strong growth
  • LHCG shows a small growth in Revenue. In the last year, the Revenue has grown by 6.44%.
  • The Revenue has been growing by 19.79% on average over the past years. This is quite good.
EPS 1Y (TTM)-25.09%
EPS 3Y18.36%
EPS 5Y22.42%
EPS Q2Q%-26.9%
Revenue 1Y (TTM)6.44%
Revenue growth 3Y7.04%
Revenue growth 5Y19.79%
Sales Q2Q%2.03%

3.2 Future

  • LHCG is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.16% yearly.
  • Based on estimates for the next years, LHCG will show a small growth in Revenue. The Revenue will grow by 7.06% on average per year.
EPS Next Y-22.68%
EPS Next 2Y-7.47%
EPS Next 3Y-2.14%
EPS Next 5Y3.16%
Revenue Next Year4.9%
Revenue Next 2Y5.12%
Revenue Next 3Y5.4%
Revenue Next 5Y7.06%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LHCG Yearly Revenue VS EstimatesLHCG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
LHCG Yearly EPS VS EstimatesLHCG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 38.68 indicates a quite expensive valuation of LHCG.
  • LHCG's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.21. LHCG is valued slightly more expensive when compared to this.
  • A Price/Forward Earnings ratio of 34.68 indicates a quite expensive valuation of LHCG.
  • 61.74% of the companies in the same industry are more expensive than LHCG, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 25.98. LHCG is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 38.68
Fwd PE 34.68
LHCG Price Earnings VS Forward Price EarningsLHCG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • LHCG's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 36.27
LHCG Per share dataLHCG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • A cheap valuation may be justified as LHCG's earnings are expected to decrease with -2.14% in the coming years.
PEG (NY)N/A
PEG (5Y)1.72
EPS Next 2Y-7.47%
EPS Next 3Y-2.14%

0

5. Dividend

5.1 Amount

  • No dividends for LHCG!.
Industry RankSector Rank
Dividend Yield N/A

LHC GROUP INC / LHCG FAQ

What is the fundamental rating for LHCG stock?

ChartMill assigns a fundamental rating of 3 / 10 to LHCG.


What is the valuation status for LHCG stock?

ChartMill assigns a valuation rating of 1 / 10 to LHC GROUP INC (LHCG). This can be considered as Overvalued.


What is the profitability of LHCG stock?

LHC GROUP INC (LHCG) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for LHCG stock?

The Earnings per Share (EPS) of LHC GROUP INC (LHCG) is expected to decline by -22.68% in the next year.